SubHero Banner

FDA announces decision to withdraw Oxandrin® (oxandrolone)

June 28, 2023 - The FDA announced the final decision to withdraw approval of brand and generic Oxandrin (oxandrolone). The FDA believes a potential problem associated with oxandrolone tablets is sufficiently serious that the drug products should be removed from the market.

Download PDF